Project Grant R01DK141555
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Washington University a $709,931 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective August 15, 2025, with a completion date of June 30, 2030. This award supports investigator-initiated basic biomedical research investigating neutrophil regulation of brown adipose tissue (BAT) homeostasis and its implications...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Washington University a $578,846 Project Grant effective February 1, 2026, through January 31, 2031, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds research investigating brown adipose tissue (BAT)-derived nidogen-2 as a potential therapeutic intervention for diabetes. The research focuses on characterizing nidogen-2's...
- Federal Project Grant Award Summary The University of Washington received a $888,773 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 15, 2026, with a completion date of January 31, 2031. This biomedical research project investigates the mechanistic contributions of hypothalamic microglia and perineuronal nets (PNNs)—specialized...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Washington University a Project Grant of $464,985 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct fundamental research on extracellular vesicles (EVs) derived from adipocytes and their role in cardiometabolic disease. The research, which commenced on June 17, 2025, and is scheduled for completion by May 31, 2030, focuses on...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $805,464 Project Grant to the University of Washington (effective August 1, 2025 through April 30, 2030) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct research on the genetic and environmental contributions to obesity pathogenesis. The research addresses a critical gap in understanding how genetic and environmental...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Washington University a Project Grant totaling $1,491,303 (awarded September 5, 2025, with completion targeted for September 4, 2029) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This research grant funds an investigator-initiated project investigating cellular senescence and the progression from acute kidney injury (AKI) to...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a Project Grant totaling $167,363 to the University of California, Los Angeles (UCLA) beginning March 1, 2026, and concluding February 28, 2031, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This research initiative investigates novel central nervous system (CNS) mechanisms underlying obesity by examining how the paraventricular...
- Federal Project Grant Award Summary Award Overview New York University received a $249,000 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective July 1, 2025, through June 30, 2028. The award supports basic biomedical research investigating the competing neurobiological mechanisms by which hunger-promoting AGRP (Agouti-Related Peptide) neurons and...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $666,229 Project Grant to the University of California, Berkeley on September 25, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This five-year award, with a completion date of June 30, 2030, funds basic biomedical research investigating neuropeptidergic mechanisms underlying hedonic feeding behavior. Specifically, the...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Washington University $465,444 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on September 15, 2025, with a completion date of July 31, 2030. This Project Grant funds basic biomedical research investigating the role of commensal fungi in intestinal wound repair and epithelial regeneration. The research will deliver...
Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Washington University a $720,353 Project Grant on March 25, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, which extends through January 31, 2031, funds basic biomedical research investigating neural circuits in the preoptic hypothalamus that regulate energy expenditure and metabolism. The research deliverables include identification and characterization of kappa opioid receptor-expressing neurons (POA-KOR+ neurons) and their role in controlling thermogenic energy expenditure, brown adipose tissue activation, and white adipose tissue remodeling. Research methodologies employed include fiber photometry, indirect calorimetry, metabolic profiling, thermal imaging, and mass spectrometry metabolomics to elucidate the circadian regulation and feeding inhibition patterns of these neural circuits. The project addresses obesity-associated metabolic diseases through investigation of hypothalamic circuit adaptation mechanisms, with the ultimate objective of identifying therapeutic targets to increase thermogenic energy expenditure and facilitate weight loss through increased brown adipose tissue activity and white adipose tissue conversion to beige adipose tissue. The research will be conducted at The Washington University's Office of Sponsored Research Services in St. Louis, Missouri, and is expected to generate fundamental scientific knowledge regarding neural regulation of energy balance and metabolism with potential therapeutic applications for metabolic health improvement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $720.4k | 3/25/26 |